source
- Making the ‘impossible’ executable in life sciences constructionWhy early technical expertise matters when complex life sciences projects challenge convention.BioPharma Dive · 1h ago↗ source
- Translating Phase II success into Phase III readiness takes more than scaleThe move from Phase II to Phase III is often treated as a clinical milestone, when it is actually a development-wide transition.BioPharma Dive · 1h ago↗ source
- State incentives for commercial-stage life sciences companiesFactor incentives into expansion plans early to improve site decisions, manage commitments and free capital for what comes next.BioPharma Dive · 1h ago↗ source